James C. Smith Elected to Pfizer’s Board of Directors
NEW YORK -- June 26, 2014
Pfizer Inc. today announced the election of James C. Smith to its Board of
Directors, effective immediately. Mr. Smith also was appointed to the
Corporate Governance and Science and Technology Committees of Pfizer’s Board.
Mr. Smith, 54, is the President and Chief Executive Officer (CEO) of Thomson
Reuters and serves on its Board of Directors. Prior to his appointment as CEO
in January 2012, he held various leadership positions at Thomson Reuters,
including CEO and Chief Operating Officer (COO) of Thomson Reuters
Professional Division. Prior to the acquisition of Reuters PLC by Thomson, he
served as COO of Thomson and President and CEO of Thomson Learning’s Academic
and Reference Group.
Mr. Smith is a member of the International Business Council of the World
Economic Forum and the Board of Directors of the Brazil-U.S. Business Council.
He also serves on the International Advisory Boards of British American
Business and the Atlantic Council.
“We are pleased to have Jim Smith join Pfizer’s Board of Directors. He brings
leadership and operational and international business experience to Pfizer’s
Board, and will be an excellent asset to the company,” stated Ian Read,
Pfizer’s Chairman and Chief Executive Officer. “The addition of Jim to our
Board helps ensure that Pfizer will continue to benefit from a breadth and
variety of experience.”
Joan Campion, 212-733-2798
Chuck Triano, 212-733-9301
Press spacebar to pause and continue. Press esc to stop.